NCBI Logo
GEO Logo
   NCBI > GEO > Accession DisplayHelp Not logged in | LoginHelp
GEO help: Mouse over screen elements for information.
          Go
Sample GSM2158841 Query DataSets for GSM2158841
Status Public on May 20, 2016
Title Patient 1, CD19+ cells, before first dose of fingolimod [exon-level]
Sample type RNA
 
Source name Peripheral blood CD19+ cells
Organism Homo sapiens
Characteristics patient identifier: QSCV-8684
gender: female
age in years at baseline: 43
disease duration in years at baseline: 20
previous treatment: interferon-beta-1a subcutaneous
treatment gap in months: 38
edss at baseline: 4.0
edss after 1 year: 3.0
edss after 2 years: 3.0
edss after 3 years: 3.0
edss after 4 years: 3.0
relapses during the year prior to fingolimod: 1
relapses during 1-year follow-up: 0
relapses during 2-year follow-up: 0
relapses during 3-year follow-up: 0
relapses during 4-year follow-up: 0
completed years of fingolimod therapy: >=4
Treatment protocol Patients were treated with fingolimod (Gilenya, Novartis) according to the approved label (0.5 mg orally once-daily) and the guidelines and recommendations of the German Society of Neurology.
Growth protocol Patient blood samples were taken immediately before the first dose of fingolimod as well as one day and three months post therapy initiation.
Extracted molecule total RNA
Extraction protocol Peripheral blood CD19+ cells were separated by magnetic-activated cell sorting using Whole Blood CD19 MicroBeads (Miltenyi Biotec) and total RNA was isolated using the mirVana isolation kit (Thermo Fisher Scientific) according to the manufacturers' protocols.
Label Biotin
Label protocol According to the Affymetrix Whole Transcript (WT) manual, cRNA was prepared from 70 ng total RNA. The cRNA was then used to generate single-stranded DNA, which was fragmented and biotinylated.
 
Hybridization protocol Labeled single-stranded DNA in the sense orientation was hybridized for 16 hours at 45 °C on Affymetrix HTA 2.0 microarrays. The microarrays were washed and stained with a streptavidin-phycoerythrin conjugate in an Affymetrix Fluidics Station 450. Signal amplification with antibodies was applied following the instructions provided by Affymetrix.
Scan protocol The microarrays were scanned with a GeneChip Scanner 3000 7G (Affymetrix).
Description Gene expression data from a multiple sclerosis patient treated with fingolimod
Data processing Data preprocessing of the raw microarray scans was performed using the Affymetrix GeneChip Command Console (AGCC) software version 4.0. The data were then processed using Expression Console version 1.3.1. The robust multi-array average (RMA) algorithm was applied with the default configuration, which includes a log2 data transformation and quantile normalization. In this step, the measured signal intensities of >6 million probes were summarized into gene level probe sets (n=70523) and exon level probe sets (n=914585). The Transcriptome Analysis Console (TAC) software version 1.0 was utilized to analyze the RNA expression dynamics.
 
Submission date May 18, 2016
Last update date Mar 22, 2018
Contact name Michael Hecker
E-mail(s) michael.hecker@rocketmail.com
Organization name University of Rostock
Department Department of Neurology
Lab Division of Neuroimmunology
Street address Gehlsheimer Str. 20
City Rostock
ZIP/Postal code 18147
Country Germany
 
Platform ID GPL17585
Series (2)
GSE73174 Transcriptome data of multiple sclerosis patients receiving fingolimod therapy
GSE81606 Transcriptome data of multiple sclerosis patients receiving fingolimod therapy [HTA-2_0, CD19+ cells, exon level]

Data table header descriptions
ID_REF
VALUE RMA signal intensity

Data table
ID_REF VALUE
JUC01000001.hg.1 5.659474
JUC01000002.hg.1 4.668868
JUC01000003.hg.1 6.609325
JUC01000004.hg.1 5.97793
JUC01000005.hg.1 7.237436
JUC01000006.hg.1 6.740088
JUC01000007.hg.1 3.634341
JUC01000008.hg.1 7.063998
JUC01000009.hg.1 0.8133034
JUC01000010.hg.1 1.50132
JUC01000011.hg.1 10.93007
JUC01000012.hg.1 8.105456
JUC01000013.hg.1 9.735624
JUC01000014.hg.1 7.739675
JUC01000015.hg.1 4.965825
JUC01000016.hg.1 6.936539
JUC01000017.hg.1 6.708949
JUC01000018.hg.1 8.470232
JUC01000019.hg.1 7.130847
JUC01000020.hg.1 7.130847

Total number of rows: 914585

Table truncated, full table size 23467 Kbytes.




Supplementary file Size Download File type/resource
GSM2158841_CD19_Pat01_baseline.CEL.gz 21.0 Mb (ftp)(http) CEL
GSM2158841_CD19_Pat01_baseline.rma-alt-splice-dabg.chp.gz 9.3 Mb (ftp)(http) CHP
Processed data included within Sample table
Processed data provided as supplementary file

| NLM | NIH | GEO Help | Disclaimer | Accessibility |
NCBI Home NCBI Search NCBI SiteMap